Navigation Links
Global miRNA Market Outlook to 2018
Date:12/24/2013

NEW YORK, Dec. 24, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, "Global miRNA Market Outlook to 2018" provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

4.1 miRNA Purification

4.2 miRNA Labeling

4.3 miRNA Linear Amplification

4.4 miRNA Microarrays

4.5 miRNA qRT-PCR

4.6 miRNA Inhibition

5. Global miRNA Market Outlook to 2018

5.1 By Geography

5.1.1 The Americas

5.1.2 Europe

5.1.3 Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

6.1 Cancer

6.2 Cardiovascular Diseases

6.3 Metabolic Diseases

6.4 Asthma

6.5 Hepatitis

7. Key Players

7.1 Mirna Therapeutics, Inc.

7.2 Rosetta Genomics, Ltd.

7.3 InteRNA Technologies B.V.

7.4 Santaris Pharma A/S

7.5 Regulus Therapeutics

7.6 miRagen Therapeutics

7.7 Qiagen

7.8 Sigma-Aldrich Corporation

7.9 Thermo Fisher Scientific Inc.

7.10 Agilent Technologies Inc.

7.11 Life Technologies Corporation

7.12 System Biosciences

7.13 GeneCopoeia

 

List of Figures:

Figure 3-1: miRNA Biogenesis

Figure 5-1: Global - miRNA Market (Million US$), 2012-2018

Figure 5-2: Ongoing miRNA Research by Geography (%), 2013

Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018

Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013

Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018

Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013

Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013

Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018

Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013

Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013

Figure 6-1: Ongoing miRNA Research by Disease (%), 2013

Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

 

List of Tables:

Table 4-1: miRNA Purification Products by Supplier

Table 4-2: miRNA Labeling Products by Supplier

Table 4-3: miRNA Linear Amplification Products by Supplier

Table 4-4: miRNA Microarray Products by Supplier

Table 4-5: miRNA qRT-PCR Products by Supplier

Table 4-6: miRNA Inhibition Products by Supplier

Table 5-1: The Americas - Ongoing miRNA Research (2013)

Table 5-2: Europe - Ongoing miRNA Research (2013)

Table 5-3: APAC - Ongoing miRNA Research (2013)

Table 6-1: miRNAs associated with Cancer

Table 6-2: miRNA associated with Cardiovascular Diseases

Table 6-3: miRNAs associated with Metabolic Disorders

Table 6-4: miRNAs associated with Hepatitis

Table 7-1: Mirna Therapeutics - miRNA Research Pipeline

Table 7-2: Rosetta Genomics - miRNA based Cancer Tests

Table 7-3: InteRNA - miRNA Research Pipeline

Table 7-4: Santaris Pharma - miRNA Research Pipeline

Table 7-5: Regulus Therapeutics - miRNA Research Pipeline

Table 7-6: miRagen - miRNA Research Pipeline

Table 7-7: Qiagen - miRNA Associated Product Line

Table 7-8: Sigma Aldrich - miRNA Associated Product Line

Table 7-9: Thermo Fisher - miRNA Associated Product Line

Table 7-10: Agilent - miRNA Associated Product Line

Table 7-11: Life Technology - miRNA Associated Product Line

Table 7-12: System Biosciences - miRNA Associated Product Line

Table 7-13: GeneCopoeia - miRNA Associated Product Line

 

To order this report: Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... SAN DIEGO , June 27, 2016  Sequenom, ... company committed to enabling healthier lives through the development ... Supreme Court of the United States ... Federal courts that the claims of Sequenom,s U.S. Patent ... the patent eligibility criteria established by the Supreme Court,s ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):